Published human trials mainly studied oral and intravenous forms, so subcutaneous amounts come from community practice rather than an approved clinical protocol
BPC-157 has been researched for supporting gut health issues (inflammatory bowel conditions, leaky gut), tendon and ligament injuries, muscle tears, joint issues, post-surgical recovery, wound healing, and chronic inflammation
But when the then-27-year-old started experiencing insomnia, he called up a doctor friend of his who suggested he get some bloodwork done
"With telogen effluvium, you will not lose all your hair, you will not go bald, and it will grow back, so it's not a permanent situation," Dr
Retatrutide is an investigational research compound that is not FDA approved